217 related articles for article (PubMed ID: 27606687)
1. Extremes of Interferon-Stimulated Gene Expression Associate with Worse Outcomes in the Acute Respiratory Distress Syndrome.
Nick JA; Caceres SM; Kret JE; Poch KR; Strand M; Faino AV; Nichols DP; Saavedra MT; Taylor-Cousar JL; Geraci MW; Burnham EL; Fessler MB; Suratt BT; Abraham E; Moss M; Malcolm KC
PLoS One; 2016; 11(9):e0162490. PubMed ID: 27606687
[TBL] [Abstract][Full Text] [Related]
2. Bacteria-specific neutrophil dysfunction associated with interferon-stimulated gene expression in the acute respiratory distress syndrome.
Malcolm KC; Kret JE; Young RL; Poch KR; Caceres SM; Douglas IS; Coldren CD; Burnham EL; Moss M; Nick JA
PLoS One; 2011; 6(7):e21958. PubMed ID: 21755013
[TBL] [Abstract][Full Text] [Related]
3. Differential type I interferon response and primary airway neutrophil extracellular trap release in children with acute respiratory distress syndrome.
Grunwell JR; Stephenson ST; Mohammad AF; Jones K; Mason C; Opolka C; Fitzpatrick AM
Sci Rep; 2020 Nov; 10(1):19049. PubMed ID: 33149247
[TBL] [Abstract][Full Text] [Related]
4. Neutrophil apoptosis: a marker of disease severity in sepsis and sepsis-induced acute respiratory distress syndrome.
Fialkow L; Fochesatto Filho L; Bozzetti MC; Milani AR; Rodrigues Filho EM; Ladniuk RM; Pierozan P; de Moura RM; Prolla JC; Vachon E; Downey GP
Crit Care; 2006; 10(6):R155. PubMed ID: 17092345
[TBL] [Abstract][Full Text] [Related]
5. Single cell transcriptomics identifies distinct profiles in pediatric acute respiratory distress syndrome.
Flerlage T; Crawford JC; Allen EK; Severns D; Tan S; Surman S; Ridout G; Novak T; Randolph A; West AN; Thomas PG
Nat Commun; 2023 Jun; 14(1):3870. PubMed ID: 37391405
[TBL] [Abstract][Full Text] [Related]
6. Dexamethasone modulates immature neutrophils and interferon programming in severe COVID-19.
Sinha S; Rosin NL; Arora R; Labit E; Jaffer A; Cao L; Farias R; Nguyen AP; de Almeida LGN; Dufour A; Bromley A; McDonald B; Gillrie MR; Fritzler MJ; Yipp BG; Biernaskie J
Nat Med; 2022 Jan; 28(1):201-211. PubMed ID: 34782790
[TBL] [Abstract][Full Text] [Related]
7. Tracheal aspirate RNA sequencing identifies distinct immunological features of COVID-19 ARDS.
Sarma A; Christenson SA; Byrne A; Mick E; Pisco AO; DeVoe C; Deiss T; Ghale R; Zha BS; Tsitsiklis A; Jauregui A; Moazed F; Detweiler AM; Spottiswoode N; Sinha P; Neff N; Tan M; Serpa PH; Willmore A; Ansel KM; Wilson JG; Leligdowicz A; Siegel ER; Sirota M; DeRisi JL; Matthay MA; ; Hendrickson CM; Kangelaris KN; Krummel MF; Woodruff PG; Erle DJ; Calfee CS; Langelier CR
Nat Commun; 2021 Aug; 12(1):5152. PubMed ID: 34446707
[TBL] [Abstract][Full Text] [Related]
8. The effect of intravenous interferon-beta-1a (FP-1201) on lung CD73 expression and on acute respiratory distress syndrome mortality: an open-label study.
Bellingan G; Maksimow M; Howell DC; Stotz M; Beale R; Beatty M; Walsh T; Binning A; Davidson A; Kuper M; Shah S; Cooper J; Waris M; Yegutkin GG; Jalkanen J; Salmi M; Piippo I; Jalkanen M; Montgomery H; Jalkanen S
Lancet Respir Med; 2014 Feb; 2(2):98-107. PubMed ID: 24503265
[TBL] [Abstract][Full Text] [Related]
9. Ketoconazole for early treatment of acute lung injury and acute respiratory distress syndrome: a randomized controlled trial. The ARDS Network.
JAMA; 2000 Apr; 283(15):1995-2002. PubMed ID: 10789668
[TBL] [Abstract][Full Text] [Related]
10. Fluorescence-Activated Cell Sorting-Based Analysis Reveals an Asymmetric Induction of Interferon-Stimulated Genes in Response to Seasonal Influenza A Virus.
von Recum-Knepper J; Sadewasser A; Weinheimer VK; Wolff T
J Virol; 2015 Jul; 89(14):6982-93. PubMed ID: 25903337
[TBL] [Abstract][Full Text] [Related]
11. A genome-wide expression analysis in blood identifies pre-elafin as a biomarker in ARDS.
Wang Z; Beach D; Su L; Zhai R; Christiani DC
Am J Respir Cell Mol Biol; 2008 Jun; 38(6):724-32. PubMed ID: 18203972
[TBL] [Abstract][Full Text] [Related]
12. Alveolar Macrophage Transcriptional Programs Are Associated with Outcomes in Acute Respiratory Distress Syndrome.
Morrell ED; Bhatraju PK; Mikacenic CR; Radella F; Manicone AM; Stapleton RD; Wurfel MM; Gharib SA
Am J Respir Crit Care Med; 2019 Sep; 200(6):732-741. PubMed ID: 30990758
[No Abstract] [Full Text] [Related]
13. Predicting candidate therapeutic drugs for sepsis-induced acute respiratory distress syndrome based on transcriptome profiling.
Ma J; Li Q; Ji D; Hong L; Luo L
Bioengineered; 2021 Dec; 12(1):1369-1380. PubMed ID: 33904373
[TBL] [Abstract][Full Text] [Related]
14. Effect of type II diabetes mellitus on outcomes in patients with acute respiratory distress syndrome.
Singla A; Turner P; Pendurthi MK; Agrawal V; Modrykamien A
J Crit Care; 2014 Feb; 29(1):66-9. PubMed ID: 24331945
[TBL] [Abstract][Full Text] [Related]
15. Investigating the Intercellular Communication Network of Immune Cell in Acute Respiratory Distress Syndrome with Sepsis.
Tao P; He J; Ai T; Fan Y; Zeng W
Comput Math Methods Med; 2022; 2022():4586648. PubMed ID: 35222683
[TBL] [Abstract][Full Text] [Related]
16. Integrated Analysis of Gene Co-Expression Network and Prediction Model Indicates Immune-Related Roles of the Identified Biomarkers in Sepsis and Sepsis-Induced Acute Respiratory Distress Syndrome.
Ming T; Dong M; Song X; Li X; Kong Q; Fang Q; Wang J; Wu X; Xia Z
Front Immunol; 2022; 13():897390. PubMed ID: 35844622
[TBL] [Abstract][Full Text] [Related]
17. [Value of procalcitonin on predicting the severity and prognosis in patients with early ARDS: a prospective observation study].
Yu Z; Ji M; Hu X; Yan J; Jin Z
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2017 Jan; 29(1):34-38. PubMed ID: 28459401
[TBL] [Abstract][Full Text] [Related]
18. Haptoglobin-2 variant increases susceptibility to acute respiratory distress syndrome during sepsis.
Kerchberger VE; Bastarache JA; Shaver CM; Nagata H; McNeil JB; Landstreet SR; Putz ND; Yu WK; Jesse J; Wickersham NE; Sidorova TN; Janz DR; Parikh CR; Siew ED; Ware LB
JCI Insight; 2019 Nov; 4(21):. PubMed ID: 31573976
[TBL] [Abstract][Full Text] [Related]
19. Epidemiological characteristics, practice of ventilation, and clinical outcome in patients at risk of acute respiratory distress syndrome in intensive care units from 16 countries (PRoVENT): an international, multicentre, prospective study.
Neto AS; Barbas CSV; Simonis FD; Artigas-Raventós A; Canet J; Determann RM; Anstey J; Hedenstierna G; Hemmes SNT; Hermans G; Hiesmayr M; Hollmann MW; Jaber S; Martin-Loeches I; Mills GH; Pearse RM; Putensen C; Schmid W; Severgnini P; Smith R; Treschan TA; Tschernko EM; Melo MFV; Wrigge H; de Abreu MG; Pelosi P; Schultz MJ; ;
Lancet Respir Med; 2016 Nov; 4(11):882-893. PubMed ID: 27717861
[TBL] [Abstract][Full Text] [Related]
20. Effect of ARDS Severity and Etiology on Short-Term Outcomes.
El-Haddad H; Jang H; Chen W; Soubani AO
Respir Care; 2017 Sep; 62(9):1178-1185. PubMed ID: 28559467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
